Chitooligosaccharides induce apoptosis in human myeloid leukemia HL-60 cells

被引:37
|
作者
Kim, Eun-Kyung [2 ,4 ]
Je, Jae-Young [3 ]
Lee, Seung-Jae [1 ]
Kim, Yon-Suk [1 ]
Hwang, Jin-Woo [1 ]
Sung, Si-Heung [2 ]
Moon, Sang-Ho [4 ]
Jeon, Byong-Tae [4 ]
Kim, Se-Kwon [5 ]
Jeon, You-Jin [6 ]
Park, Pyo-Jam [1 ,4 ]
机构
[1] Konkuk Univ, Dept Biotechnol, Chungju 380701, South Korea
[2] Konkuk Univ, Dept Food Life Sci, Chungju 380701, South Korea
[3] Chonnam Natl Univ, Dept Food Technol & Nutr, Yeosu 350749, South Korea
[4] Konkuk Univ, Korean Nokyong Res Ctr, Chungju 380701, South Korea
[5] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea
[6] Jeju Natl Univ, Fac Appl Marine Sci, Cheju 690756, South Korea
关键词
Hetero-chitooligosaccharide; Deacetylation; Molecular weight; Anticancer; HETERO-CHITOOLIGOSACCHARIDES; ANTIMICROBIAL ACTIVITY; CHITOSAN; CANCER; PREVENTION; WEIGHT;
D O I
10.1016/j.bmcl.2012.08.030
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study we propose a novel anticancer agent using hetero-chitooligosaccharide (hetero-COS). To examine the possibility of the hetero-COS as a anticancer agent, we prepared nine kinds of hetero-COS with relatively higher molecular weights (90, 75 and 50-COS I, 5 similar to 10 kDa), medium molecular weights (90, 75 and 50-COS II, 1 similar to 5 kDa), and lower molecular weights (90, 75 and 50-III, below 1 kDa), and their anticancer properties were investigated on HL-60 cells using flow cytometry and morphological analysis. The results obtained indicate that 90-COS III, which is relatively higher degree of deacetylation and lower molecular weights, showed the highest anticancer activity, and the data showed the anticancer property of the hetero-COSs depended on their degree of deacetylation values and molecular weight. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6136 / 6138
页数:3
相关论文
共 50 条
  • [1] Endomorphins, endogenous opioid peptides, induce apoptosis in human leukemia HL-60 cells
    Lin, X
    Chen, Q
    Xue, LY
    Ma, XJ
    Wang, R
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2004, 82 (11) : 1018 - 1025
  • [2] Sasa quelpaviensis leaf extracts induce apoptosis in human leukemia HL-60 cells
    Jang, Mi-Gyeong
    Park, Soo-Young
    Lee, Sun-Ryung
    Choi, Soo-Youn
    Hwang, Joon-Ho
    Ko, Hee-Chul
    Park, Ji-Gweon
    Chung, Wan-Seok
    Kim, Se-Jae
    [J]. FOOD SCIENCE AND BIOTECHNOLOGY, 2008, 17 (01) : 188 - 190
  • [3] Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells
    Yun-feng WAN
    1United Gene Scientific Technology Company
    [J]. Acta Pharmacologica Sinica, 2004, (03) : 124 - 130
  • [4] α-tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells
    Huang, Huarong
    Chen, Shaohua
    Van Doren, Jeremiah
    Li, Dongli
    Farichon, Chelsea
    He, Yan
    Zhang, Qiuyan
    Zhang, Kun
    Conney, Allan H.
    Goodin, Susan
    Du, Zhiyun
    Zheng, Xi
    [J]. MOLECULAR MEDICINE REPORTS, 2015, 11 (06) : 4573 - 4578
  • [5] Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells
    Wan, YF
    Guo, XQ
    Wang, ZH
    Ying, K
    Yao, MH
    [J]. ACTA PHARMACOLOGICA SINICA, 2004, 25 (03) : 378 - 384
  • [6] APOPTOSIS INDUCED BY ADENOSINE IN HUMAN LEUKEMIA HL-60 CELLS
    TANAKA, Y
    YOSHIHARA, K
    TSUYUKI, M
    KAMIYA, T
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 213 (01) : 242 - 252
  • [7] Securinine induced apoptosis in human leukemia HL-60 cells
    Dong, NZ
    Gu, ZL
    Chou, WH
    Kwok, CY
    [J]. ACTA PHARMACOLOGICA SINICA, 1999, 20 (03): : 267 - 270
  • [8] Quercetin induced apoptosis in human leukemia HL-60 cells
    Xiao, D
    Zhu, SP
    Gu, ZL
    [J]. ACTA PHARMACOLOGICA SINICA, 1997, 18 (03): : 280 - 283
  • [9] Erianin induces apoptosis in human leukemia HL-60 cells
    Li, YM
    Wang, HY
    Liu, GQ
    [J]. ACTA PHARMACOLOGICA SINICA, 2001, 22 (11): : 1018 - 1022
  • [10] Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells
    Huang, Qinwan
    Wang, Lin
    Ran, Qian
    Wang, Jin
    Wang, Chengqiang
    He, Hui
    Li, Li
    Qi, Hongyi
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1927 - 1940